Long-term IgG response to porcine Neu5Gc antigens without transmission of PERV in burn patients treated with porcine skin xenografts

Journal of Immunology

Volumn 191, Issue 6, 2013, Pages 2907-2915

  Scobie, Linda ^a   Padler Karavani, Vered ^b   Le Bas Bernardet, Stephanie ^c   Crossan, Claire ^a   Blaha, Josef ^d   Matouskova, Magda ^e   Hector, Ralph D ^a   Cozzi, Emanuele ^f,g   Vanhove, Bernard ^c   Charreau, Beatrice ^c   Blancho, Gilles ^c   Bourdais, Ludovic ^c   Tallacchini, Mariachiara ^h   Ribes, Juan M ⁱ   Yu, Hai ^j   Chen, Xi ^j   Kracikova, Jitka ^d   Broz, Ludomir ^d   Hejnar, Jiri ^e   Vesely, Pavel ^d,k   Takeuchi, Yasuhiro ⁱ   Varki, Ajit ^b   Soulillou, Jean Paul ^c   more..

^a GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NANTES UNIVERSITY HOSPITAL   (France)

^d CHARLES UNIVERSITY   (Czech Republic)

^e INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

^f UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^g Consortium for Research in Organ Transplantation ^*  (Italy)

^h UNIVERSITÀ CATTOLICA DEL SACRO CUORE   (Italy)

ⁱ UNIVERSITY COLLEGE LONDON   (United Kingdom)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k BRNO UNIVERSITY OF TECHNOLOGY   (Czech Republic)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; IMMUNOGLOBULIN G; NEU5GC ANTIGEN; SIALIC ACID; SIALOGLYCOPROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; BURN; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; PANCREAS ISLET; PORCINE ENDOGENOUS RETROVIRUS; PRESCHOOL CHILD; PRIORITY JOURNAL; RECIPIENT; RETROVIRUS; SCHOOL CHILD; SKIN TRANSPLANTATION; TISSUE IMPLANT; VIRUS TRANSMISSION; XENOGRAFT; XENOTRANSPLANTATION;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIGENS, HETEROPHILE; BURNS; CHILD; ENDOGENOUS RETROVIRUSES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; INFANT; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SIALIC ACIDS; SKIN TRANSPLANTATION; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 84884242906     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301195     Document Type: Article

References (67)

1. Ekser, B., M. Ezzelarab, H. Hara, D. J. van der Windt, M. Wijkstrom, R. Bottino, M. Trucco, and D. K. Cooper. 2012. Clinical xenotransplantation the next medical revolution? Lancet 379: 672-683.
2. Sgroi, A., L. H. Bühler, P. Morel, M. Sykes, and L. Noel. 2010. International human xenotransplantation inventory. Transplantation 90: 597-603.
3. Elliott, R. B.; Living Cell Technologies. 2011. Towards xenotransplantation of pig islets in the clinic. Curr. Opin. Organ Transplant. 16: 195-200.
4. Levy, M. F., J. Crippin, S. Sutton, G. Netto, J. McCormack, T. Curiel, R. M. Goldstein, J. T. Newman, T. A. Gonwa, J. Banchereau, et al. 2000. Liver allotransplantation after extracorporeal hepatic support with transgenic (hCD55/ hCD59) porcine livers: clinical results and lack of pig-to-human transmission of the porcine endogenous retrovirus. Transplantation 69: 272-280.
5. Gu, C., X. Wei, Y. Wang, Y. Chen, J. Liu, H. Wang, G. Sun, and D. Yi. 2008. No infection with porcine endogenous retrovirus in recipients of acellular porcine aortic valves: a two-year study. Xenotransplantation 15: 121-128.
6. Stapleton, T. W., J. Ingram, J. Katta, R. Knight, S. Korossis, J. Fisher, and E. Ingham. 2008. Development and characterization of an acellular porcine medial meniscus for use in tissue engineering. Tissue Eng. Part A 14: 505-518.
7. Nasajpour, H., K. A. LeBlanc, and M. H. Steele. 2011. Complex hernia repair using component separation technique paired with intraperitoneal acellular porcine dermis and synthetic mesh overlay. Ann. Plast. Surg. 66: 280-284.
8. Dvoránková, B., L. Broz, I. Pafcuga, Z. Kapounková, and R. Königová. 2004. The role of skin bank in the treatment of severely burnt patients. Acta Chir. Plast. 46: 51-55.
9. Ge, L., L. Sun, J. Chen, X. Mao, Y. Kong, F. Xiong, J. Wu, and H. Wei. 2010. The viability change of pigskin in vitro. Burns 36: 533-538.
10. Takeuchi, Y., and J. Fishman. 2010. Long life with or without PERV. Xenotransplantation 17: 429-430.
11. Galili, U. 2012. Induced anti-non gal antibodies in human xenograft recipients. Transplantation 93: 11-16.
12. Breimer, M. E. 2011. Gal/non-Gal antigens in pig tissues and human non-Gal antibodies in the GalT-KO era. Xenotransplantation 18: 215-228.
13. Paradis, K., G. Langford, Z. Long, W. Heneine, P. Sandstrom, W. M. Switzer, L. E. Chapman, C. Lockey, D. Onions, and E. Otto. 1999. Search for crossspecies transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group. Science 285: 1236-1241.
14. Di Nicuolo, G., A. D'Alessandro, B. Andria, V. Scuderi, M. Scognamiglio, A. Tammaro, A. Mancini, S. Cozzolino, E. Di Florio, A. Bracco, et al. 2010. Long-term absence of porcine endogenous retrovirus infection in chronically immunosuppressed patients after treatment with the porcine cell-based Academic Medical Center bioartificial liver. Xenotransplantation 17: 431-439.
15. Heneine, W., A. Tibell,W. M. Switzer, P. Sandstrom, G. V. Rosales, A. Mathews, O. Korsgren, L. E. Chapman, T. M. Folks, and C. G. Groth. 1998. No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts. Lancet 352: 695-699.
16. Irgang, M., I. M. Sauer, A. Karlas, K. Zeilinger, J. C. Gerlach, R. Kurth, P. Neuhaus, and J. Denner. 2003. Porcine endogenous retroviruses: no infection in patients treated with a bioreactor based on porcine liver cells. J. Clin. Virol. 28: 141-154.
17. Patience, C., G. S. Patton, Y. Takeuchi, R. A.Weiss, M. O. McClure, L. Rydberg, and M. E. Breimer. 1998. No evidence of pig DNA or retroviral infection in patients with short-term extracorporeal connection to pig kidneys. Lancet 352: 699-701.
18. Valdes-Gonzalez, R., L. M. Dorantes, E. Bracho-Blanchet, A. Rodríguez-Ventura, and D. J. White. 2010. No evidence of porcine endogenous retrovirus in patients with type 1 diabetes after long-term porcine islet xenotransplantation. J. Med. Virol. 82: 331-334.
19. Valdes-Gonzalez, R., A. L. Rodriguez-Ventura, D. J. White, E. Bracho-Blanchet, A. Castillo, B. Ramírez-González, M. G. López-Santos, B. H. León-Mancilla, and L. M. Dorantes. 2010. Long-term follow-up of patients with type 1 diabetes transplanted with neonatal pig islets. Clin. Exp. Immunol. 162: 537-542.
20. Denner, J. 2008. Is porcine endogenous retrovirus (PERV) transmission still relevant? Transplant. Proc. 40: 587-589.
21. Fishman, J. A., L. Scobie, and Y. Takeuchi. 2012. Xenotransplantationassociated infectious risk: a WHO consultation. Xenotransplantation 19: 72-81.
22. Rose, A. G., D. K. Cooper, P. A. Human, H. Reichenspurner, and B. Reichart. 1991. Histopathology of hyperacute rejection of the heart: experimental and clinical observations in allografts and xenografts. J. Heart Lung Transplant. 10: 223-234.
23. Oriol, R., Y. Ye, E. Koren, and D. K. Cooper. 1993. Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation. Transplantation 56: 1433-1442.
24. Cozzi, E., and D. J. White. 1995. The generation of transgenic pigs as potential organ donors for humans. Nat. Med. 1: 964-966.
25. Cooper, D. K., E. Koren, and R. Oriol. 1994. Oligosaccharides and discordant xenotransplantation. Immunol. Rev. 141: 31-58.
26. Sandrin, M. S., and I. F. McKenzie. 1994. Gal alpha (1,3)Gal, the major xenoantigen( s) recognised in pigs by human natural antibodies. Immunol. Rev. 141: 169-190.
27. Macher, B. A., and U. Galili. 2008. The Galalpha1,3Galbeta1,4GlcNAc-R (alpha-Gal) epitope: a carbohydrate of unique evolution and clinical relevance. Biochim. Biophys. Acta 1780: 75-88.
28. Galili, U. 2005. The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy. Immunol. Cell Biol. 83: 674-686.
29. Lindeborg, E., M. Kumagai-Braesch, A. Tibell, and E. Möller. 2001. Continued production of xenoimmune antibodies 6-8 years after clinical transplantation of fetal pig islet-like cell-clusters. Xenotransplantation 8: 273-283.
30. Kuwaki, K., Y. L. Tseng, F. J. Dor, A. Shimizu, S. L. Houser, T. M. Sanderson, C. J. Lancos, D. D. Prabharasuth, J. Cheng, K. Moran, et al. 2005. Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat. Med. 11: 29-31.
31. Yamada, K., K. Yazawa, A. Shimizu, T. Iwanaga, Y. Hisashi, M. Nuhn, P. O'Malley, S. Nobori, P. A. Vagefi, C. Patience, et al. 2005. Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue. Nat. Med. 11: 32-34.
32. Cooper, D. K., A. Dorling, R. N. Pierson, III, M. Rees, J. Seebach, M. Yazer, H. Ohdan, M. Awwad, and D. Ayares. 2007. Alpha1,3-galactosyltransferase geneknockout pigs for xenotransplantation: where do we go from here? Transplantation 84: 1-7.
33. Fujimura, T., Y. Takahagi, T. Shigehisa, H. Nagashima, S. Miyagawa, R. Shirakura, and H. Murakami. 2008. Production of alpha 1,3-galactosyltransferase gene-deficient pigs by somatic cell nuclear transfer: a novel selection method for gal alpha 1,3-Gal antigen-deficient cells. Mol. Reprod. Dev. 75: 1372-1378.
34. Phelps, C. J., C. Koike, T. D. Vaught, J. Boone, K. D. Wells, S. H. Chen, S. Ball, S. M. Specht, I. A. Polejaeva, J. A. Monahan, et al. 2003. Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 299: 411-414.
35. Kolber-Simonds, D., L. Lai, S. R. Watt, M. Denaro, S. Arn, M. L. Augenstein, J. Betthauser, D. B. Carter, J. L. Greenstein, Y. Hao, et al. 2004. Production of alpha-1,3-galactosyltransferase null pigs by means of nuclear transfer with fibroblasts bearing loss of heterozygosity mutations. Proc. Natl. Acad. Sci. USA 101: 7335-7340.
36. Bouhours, D., J. Liaigre, J. Lemoine, F. Mayer-Posner, and J. F. Bouhours. 1998. Two novel isoneolacto-undecaglycosylceramides carrying Galalpha1-.3Lewis (x) on the 6-linked antenna and N-acetylneuraminic acidalpha2-.3 or Galactose alpha1-.3 on the 3-linked antenna, expressed in porcine kidney. Glycoconj. J. 15: 1001-1016.
37. Zhu, A., and R. Hurst. 2002. Anti-N-glycolylneuraminic acid antibodies identified in healthy human serum. Xenotransplantation 9: 376-381.
38. Chen, G., H. Qian, T. Starzl, H. Sun, B. Garcia, X. Wang, Y. Wise, Y. Liu, Y. Xiang, L. Copeman, et al. 2005. Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys. Nat. Med. 11: 1295-1298.
39. Miwa, Y., T. Kobayashi, T. Nagasaka, D. Liu, M. Yu, I. Yokoyama, A. Suzuki, and A. Nakao. 2004. Are N-glycolylneuraminic acid (Hanganutziu-Deicher) antigens important in pig-to-human xenotransplantation? Xenotransplantation 11: 247-253.
40. Ezzelarab, M., D. Ayares, and D. K. Cooper. 2005. Carbohydrates in xenotransplantation. Immunol. Cell Biol. 83: 396-404.
41. Tangvoranuntakul, P., P. Gagneux, S. Diaz, M. Bardor, N. Varki, A. Varki, and E. Muchmore. 2003. Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid. Proc. Natl. Acad. Sci. USA 100: 12045-12050.
42. Varki, A. 2010. Colloquium paper: uniquely human evolution of sialic acid genetics and biology. Proc. Natl. Acad. Sci. USA 107(Suppl 2): 8939-8946.
43. Padler-Karavani, V., and A. Varki. 2011. Potential impact of the non-human sialic acid N-glycolylneuraminic acid on transplant rejection risk. Xenotransplantation 18: 1-5.
44. Pham, T., C. J. Gregg, F. Karp, R. Chow, V. Padler-Karavani, H. Cao, X. Chen, J. L. Witztum, N. M. Varki, and A. Varki. 2009. Evidence for a novel humanspecific xeno-auto-antibody response against vascular endothelium. Blood 114: 5225-5235.
45. Hedlund, M., V. Padler-Karavani, N. M. Varki, and A. Varki. 2008. Evidence for a human-specific mechanism for diet and antibody-mediated inflammation in carcinoma progression. Proc. Natl. Acad. Sci. USA 105: 18936-18941.
46. Padler-Karavani, V., N. Hurtado-Ziola, M. Pu, H. Yu, S. Huang, S. Muthana, H. A. Chokhawala, H. Cao, P. Secrest, D. Friedmann-Morvinski, et al. 2011. Human xeno-autoantibodies against a non-human sialic acid serve as novel serum biomarkers and immunotherapeutics in cancer. Cancer Res. 71: 3352-3363.
47. Zajicek, R., E. Matouskova, L. Broz, R. Kubok, P. Waldauf, and R. Königova. 2011. New biological temporary skin cover Xe-Derma in the treatment of superficial scald burns in children. Burns 37: 333-337.
48. Broz, L., D. Vogtová, and R. Königová. 1999. Experience with banked skin in the Prague Burn Center. Acta Chir. Plast. 41: 54-58.
49. Bartosch, B., D. Stefanidis, R. Myers, R. Weiss, C. Patience, and Y. Takeuchi. 2004. Evidence and consequence of porcine endogenous retrovirus recombination. J. Virol. 78: 13880-13890.
50. Mattiuzzo, G., Y. Takeuchi, and L. Scobie. 2012. Potential zoonotic infection of porcine endogenous retrovirus in xenotransplantation. Methods Mol. Biol. 885: 263-279.
51. Wood, J. C., G. Quinn, K. M. Suling, B. A. Oldmixon, B. A. Van Tine, R. Cina, S. Arn, C. A. Huang, L. Scobie, D. E. Onions, et al. 2004. Identification of exogenous forms of human-tropic porcine endogenous retrovirus in miniature Swine. J. Virol. 78: 2494-2501.
52. Wood, A., B. L. Webb, B. Bartosch, T. Schaller, Y. Takeuchi, and G. J. Towers. 2009. Porcine endogenous retroviruses PERV A and A/C recombinant are insensitive to a range of divergent mammalian TRIM5alpha proteins including human TRIM5alpha. J. Gen. Virol. 90: 702-709.
53. Buonomano, R., C. Tinguely, R. Rieben, P. J. Mohacsi, and U. E. Nydegger. 1999. Quantitation and characterization of anti-Galalpha1-3Gal antibodies in sera of 200 healthy persons. Xenotransplantation 6: 173-180.
54. Chatelais, M., J. Devallière, C. Galli, and B. Charreau. 2011. Gene transfer of the adaptor Lnk (SH2B3) prevents porcine endothelial cell activation and apoptosis: implication for xenograft's cytoprotection. Xenotransplantation 18: 108-120.
55. Padler-Karavani, V., A. H. Tremoulet, H. Yu, X. Chen, J. C. Burns, and A. Varki. 2013. A simple method for assessment of human anti-Neu5Gc antibodies applied to Kawasaki disease. PLoS ONE 8: e58443.
56. Padler-Karavani, V., X. Song, H. Yu, N. Hurtado-Ziola, S. Huang, S. Muthana, H. A. Chokhawala, J. Cheng, A. Verhagen, M. A. Langereis, et al. 2012. Crosscomparison of protein recognition of sialic acid diversity on two novel sialoglycan microarrays. J. Biol. Chem. 287: 22593-22608.
57. Lutz, A. J., P. Li, J. L. Estrada, R. A. Sidner, R. K. Chihara, S. M. Downey, C. Burlak, Z. Y. Wang, L. M. Reyes, B. Ivary, et al. 2013. Double knockout pigs deficient in N-glycolylneuraminic acid and Galactose a-1,3-Galactose reduce the humoral barrier to xenotransplantation. Xenotransplantation 20: 27-35.
58. Davies, L. R., O. M. Pearce, M. B. Tessier, S. Assar, V. Smutova, M. Pajunen, M. Sumida, C. Sato, K. Kitajima, J. Finne, et al. 2012. Metabolism of vertebrate amino sugars with N-glycolyl groups: resistance of a2-8-linked N-glycolylneuraminic acid to enzymatic cleavage. J. Biol. Chem. 287: 28917-28931.
59. Varki, A., and S. Diaz. 1984. The release and purification of sialic acids from glycoconjugates: methods to minimize the loss and migration of O-acetyl groups. Anal. Biochem. 137: 236-247.
60. Lu, Q., V. Padler-Karavani, H. Yu, X. Chen, S. L. Wu, A. Varki, and W. S. Hancock. 2012. LC-MS analysis of polyclonal human anti-Neu5Gc xenoautoantibodies immunoglobulin G Subclass and partial sequence using multistep intravenous immunoglobulin affinity purification and multienzymatic digestion. Anal. Chem. 84: 2761-2768.
61. Dufrane, D., R. M. Goebbels, and P. Gianello. 2010. Alginate macroencapsulation of pig islets allows correction of streptozotocin-induced diabetes in primates up to 6 months without immunosuppression. Transplantation 90: 1054-1062.
62. Chou, H. H., H. Takematsu, S. Diaz, J. Iber, E. Nickerson, K. L. Wright, E. A. Muchmore, D. L. Nelson, S. T. Warren, and A. Varki. 1998. A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence. Proc. Natl. Acad. Sci. USA 95: 11751-11756.
63. Irie, A., S. Koyama, Y. Kozutsumi, T. Kawasaki, and A. Suzuki. 1998. The molecular basis for the absence of N-glycolylneuraminic acid in humans. J. Biol. Chem. 273: 15866-15871.
64. Jeschke, M. G., G. G. Gauglitz, G. A. Kulp, C. C. Finnerty, F. N. Williams, R. Kraft, O. E. Suman, R. P. Mlcak, and D. N. Herndon. 2011. Long-term persistance of the pathophysiologic response to severe burn injury. PLoS ONE 6: e21245.
65. Defrance, T., M. Taillardet, and L. Genestier. 2011. T cell-independent B cell memory. Curr. Opin. Immunol. 23: 330-336.
66. Amanna, I. J., and M. K. Slifka. 2010. Mechanisms that determine plasma cell lifespan and the duration of humoral immunity. Immunol. Rev. 236: 125-138.
67. El Shikh, M. E., R. M. El Sayed, S. Sukumar, A. K. Szakal, and J. G. Tew. 2010. Activation of B cells by antigens on follicular dendritic cells. Trends Immunol. 31: 205-211.